Citizens reiterates Core Scientific stock rating on contracted capacity
Citizens reiterated a Market Outperform rating and $30 price target for Core Scientific (CORZ), citing its 1.1 GW contracted portfolio and expected earnings growth. The stock has fallen 44.5% in six months. Core Scientific reported 77% revenue growth and Q3 2026 earnings with colocation revenue at $215M and adjusted EBITDA at $134M. Craig-Hallum lowered its target to $25 but maintained a Buy rating.
How this was made
The 30-second read
Why it matters
Analyst rating lift could trigger short covering and new buying, but valuation concerns remain.
Market read
The rating upgrade provides a fresh catalyst for CORZ, potentially influencing sector sentiment.
What to watch
Potential delays in AMD build completion and permitting risks could temper upside.
Background
Core Scientific is expanding its contracted data center capacity and seeking permits for new projects.
Ticker impact
Citizens reiterated a Market Outperform rating and raised the price target to $30 for Core Scientific (CORZ).
likely upward pressure as investors price in the new target
Rating change and target increase are fresh analyst actions that can move the stock.
Market effects
Positive outlook may boost sentiment in the data center and crypto mining sector.
Limited to US investors focused on cloud infrastructure stocks.
Minimal global impact beyond sector peers.
Counterpoint
The high EV/EBITDA multiple suggests the stock may still be overvalued despite the upgrade.
Key entities
- AnalystCitizens
Issued Market Outperform rating and $30 price target for Core Scientific.
- CompanyCore Scientific Inc.
Data center and crypto mining operator with growing contracted capacity.



